Biogen aims to block Tecfidera generics with flurry of lawsuits
July 04, 2017 at 18:41 PM EDT
In recent weeks, the Cambridge drugmaker has accused more than two dozen generic drugmakers of infringing patents on the blockbuster multiple sclerosis treatment.